Daiwa Securities Group Inc. - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 229 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4
-20.0%
630.0%0.00%
Q2 2023$50.0%630.0%0.00%
Q1 2023$5
+25.0%
630.0%0.00%
Q4 2022$4
-99.9%
630.0%0.00%
Q3 2022$5,000
-16.7%
630.0%0.00%
Q2 2022$6,0000.0%63
+28.6%
0.00%
Q1 2022$6,000
-25.0%
490.0%0.00%
Q4 2021$8,0000.0%49
-14.0%
0.00%
Q3 2021$8,000
+100.0%
57
+72.7%
0.00%
Q2 2021$4,000
-20.0%
330.0%0.00%
Q1 2021$5,000
+66.7%
33
+10.0%
0.00%
Q4 2020$3,000
-66.7%
30
-67.4%
0.00%
Q3 2020$9,000
+28.6%
920.0%0.00%
Q2 2020$7,0000.0%920.0%0.00%
Q1 2020$7,000
-30.0%
92
-7.1%
0.00%
Q4 2019$10,000
-16.7%
99
-19.5%
0.00%
Q3 2019$12,000
-14.3%
1230.0%0.00%
Q2 2019$14,000
-12.5%
123
-5.4%
0.00%
Q1 2019$16,0000.0%130
+11.1%
0.00%
Q4 2018$16,000
-50.0%
1170.0%0.00%
Q3 2018$32,000
+33.3%
1170.0%0.00%
Q2 2018$24,000
+26.3%
1170.0%0.00%
Q1 2018$19,0001170.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Knott David M Jr 115,000$6,8912.63%
VILLERE ST DENIS J & CO LLC 438,161$26,254,6072.24%
RICE HALL JAMES & ASSOCIATES, LLC 282,961$16,955,0231.08%
Chicago Capital, LLC 360,345$21,591,8841.01%
CARDINAL CAPITAL MANAGEMENT LLC /CT 206,399$12,367,4280.53%
Smith, Graham & Co., Investment Advisors, LP 61,849$3,705,9920.46%
Stephens Investment Management Group LLC 467,564$28,016,4350.46%
Jackson Creek Investment Advisors LLC 13,657$8180.34%
Court Place Advisors, LLC 15,133$906,7690.32%
Ziegler Capital Management, LLC 123,158$7,379,1760.30%
View complete list of LIGAND PHARMACEUTICALS INC shareholders